Mindstrong

Mindstrong Health, founded in 2014, is committed to using artificial intelligence and mobile technology to help diagnose human neuropsychiatric disorders. Mindstrong was listed among the Fierce 15 medical technology companies by the U.S.-based FierceBiotech website in 2019, as well as on CB Insights' AI 100 list. In early 2018, it entered into a research collaboration with Takeda to help discover digital biomarkers for schizophrenia and treatment-resistant depression.Mindstrong Health has established a continuous cognitive and psychiatric measurement system, providing diagnostic and treatment solutions through an App designed for both doctors and patients. The company has developed technology for remote patient monitoring and measuring mental health symptoms. Its internal team of therapists, psychiatrists, and care coordinators uses this technological platform to provide flexible, efficient, and seamlessly integrated virtual care to patients.Mindstrong Health aims to improve clinical outcomes and reduce the number of patient visits by offering smarter brain health care. What truly attracts investors to Mindstrong is not the "mental health tracking tool," but the "mental health early warning tool." By collecting behavioral data from users' smartphone usage, Mindstrong can detect patterns of negative mental states.